Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on Form N-CSR on March 04, 2025 from CEO & President, Michael Feldschuh.
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Seeking Alpha / 1 hour from now 1 Views
Comments